Background: Among the patients with bladder cancer, a group is still at risk of disease recurrence, progression, and death from their cancer after curative treatment. Angiogenesis is a crucial pathogenic mechanism for this type of urothelial carcinoma and is a potential therapeutic target.
Objectives: To quantify tumor angiogenesis in bladder cancer and determine whether it correlates with tumor stage and grade.